CS logo
small CS logo
Grant Medical Center Cancer Care

Columbus, Ohio, United States

About Grant Medical Center Cancer Care


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Grant Medical Center Cancer Care


During the past decade, Grant Medical Center Cancer Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 58 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
2009-03-25
2012-10-18
Terminated
105
Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
2010-08-01
2013-10-01
Completed
800
Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
2011-02-01
2014-02-01
Completed
799
Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women
2012-10-24
2018-09-06
Completed
583
Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
2013-03-12
2018-10-03
Completed
872

Rows per page:

1–5 of 5

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Grant Medical Center Cancer Care" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 45 trials, followed by "SWOG Cancer Research Network" with 37 trials sponsored, "Eastern Cooperative Oncology Group" with 11 trials sponsored, "NSABP Foundation Inc" with 7 trials sponsored and "Radiation Therapy Oncology Group" with 7 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Grant Medical Center Cancer Care" #1 collaborator was "National Cancer Institute (NCI)" with 114 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "Eastern Cooperative Oncology Group" with 6 trials as a collaborator and "NRG Oncology" with 6 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 16 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Grant Medical Center Cancer Care


According to Clinical.Site data, the most researched conditions in "Grant Medical Center Cancer Care" are "Breast Cancer" (26 trials), "Lung Cancer" (14 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials), "Lymphoma" (11 trials) and "Leukemia" (8 trials). Many other conditions were trialed in "Grant Medical Center Cancer Care" in a lesser frequency.

Clinical Trials Intervention Types at Grant Medical Center Cancer Care


Most popular intervention types in "Grant Medical Center Cancer Care" are "Drug" (80 trials), "Other" (39 trials), "Biological" (30 trials), "Radiation" (20 trials) and "Procedure" (13 trials). Other intervention types were less common.
The name of intervention was led by "placebo" (23 trials), "bevacizumab" (12 trials), "cisplatin" (10 trials), "radiation therapy" (9 trials) and "cyclophosphamide" (8 trials). Other intervention names were less common.

Clinical Trials Genders at Grant Medical Center Cancer Care


The vast majority of trials in "Grant Medical Center Cancer Care" are 88 trials for "All" genders, 19 trials for "Female" genders and 8 trials for "Male" genders.

Clinical Trials Status at Grant Medical Center Cancer Care


Currently, there are NaN active trials in "Grant Medical Center Cancer Care". undefined are not yet recruiting, undefined are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 95 completed trials in Grant Medical Center Cancer Care, undefined suspended trials, and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Grant Medical Center Cancer Care, 2 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status